{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:15Z","timestamp":1786119555179,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Dapsone is used for treating infectious and immunological disorders, but it may cause dapsone hypersensitivity syndrome (DHS), a serious concern for medical staff. However, in non-leprotic patients, the manifestations of DHS can be atypical and various, leading to diagnostic challenges and potential delays in treatment initiation, which requires attention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 17-year-old Chinese male developed DHS after 3-week dapsone treatment for vasculitis, showing the risk of dapsone use in young patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>DHS symptoms include fever, rash, and lymphadenopathy, which can be life-threatening. Diagnosis for this patient was based on symptom recognition, medical history review, physical examination, and the link between dapsone intake and symptom onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Once diagnosed, dapsone was withdrawn immediately. Corticosteroids were given to reduce inflammation, and antipyretics and anti-histamines were used for symptom relief.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>After treatment, the patient improved. Fever subsided quickly, the rash resolved in a week, and lymphadenopathy shrank. Follow-up showed full recovery with no symptom recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This report details a case and reviews published cases of DHS. Summarizing their features aims to improve diagnostic accuracy and management strategies, thus helping healthcare providers handle similar cases better.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000043073","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:01:06Z","timestamp":1751904066000},"page":"e43073","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Non-leprosy related dapsone hypersensitivity syndrome: A case report and literature review"],"prefix":"10.1097","volume":"104","author":[{"given":"Hang-Qi","family":"Zhu","sequence":"first","affiliation":[{"name":"The Second Hospital Affiliated to Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Hua","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Second Hospital Affiliated to Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Lin","family":"Song","sequence":"additional","affiliation":[{"name":"The Second Hospital Affiliated to Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250707","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-6673-1-9","article-title":"The Dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations.","volume":"1","author":"Kosseifi","year":"2006","journal-title":"J Occup Med Toxicol"},{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(51)91443-2","article-title":"Toxic effects of diaminodiphenylsulphone in treatment of leprosy.","volume":"2","author":"Allday","year":"1951","journal-title":"Lancet"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00403-013-1409-7","article-title":"Dapsone in dermatology and beyond.","volume":"306","author":"Wozel","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"R4-20250707","first-page":"181","article-title":"The chemotherapy of leprosy in Nigeria; with an appendix on glandular fever and exfoliative dermatitis precipitated by sulfones.","volume":"17","author":"Lowe","year":"1949","journal-title":"Int J Lepr"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11882-023-01109-7","article-title":"Overview and current advances in dapsone hypersensitivity syndrome.","volume":"23","author":"Wang","year":"2023","journal-title":"Curr Allergy Asthma Rep"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archderm.1981.01650010044023","article-title":"Dapsone hypersensitivity. The sulfone syndrome revisited.","volume":"117","author":"Tomecki","year":"1981","journal-title":"Arch Dermatol"},{"key":"R7-20250707","first-page":"267","article-title":"Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy.","volume":"60","author":"Richardus","year":"1989","journal-title":"Lepr Rev"},{"key":"R8-20250707","first-page":"105","article-title":"Dapsone syndrome--first Malaysian paediatric case report.","volume":"67","author":"Zurina","year":"2012","journal-title":"Med J Malaysia"},{"key":"R9-20250707","first-page":"268","article-title":"Severe dapsone hypersensitivity syndrome.","volume":"16","author":"Sener","year":"2006","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.4269\/ajtmh.16-0628","article-title":"A review on dapsone hypersensitivity syndrome among Chinese patients with an emphasis on preventing adverse drug reactions with genetic testing.","volume":"96","author":"Wang","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"R11-20250707","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/09546630802691317","article-title":"Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.","volume":"20","author":"Sheen","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/qjmed\/hcv209","article-title":"Severe cutaneous vasculitis: an unusual complication of equine antithymocyte globulin treatment.","volume":"109","author":"Vinod","year":"2016","journal-title":"QJM"},{"issue":"Suppl 3","key":"R13-20250707","doi-asserted-by":"crossref","first-page":"S290","DOI":"10.5021\/ad.2011.23.S3.S290","article-title":"Dapsone hypersensitivity syndrome that occurred during treatment of pediatric patient with erythema elevatum diutinum.","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4132\/KoreanJPathol.2012.46.6.606","article-title":"Cervical lymphadenopathy mimicking angioimmunoblastic T-cell lymphoma after dapsone-induced hypersensitivity syndrome.","volume":"46","author":"Rim","year":"2012","journal-title":"Korean J Pathol"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1046\/j.1365-2230.2003.01336.x","article-title":"A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.","volume":"28","author":"Leslie","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"R16-20250707","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2710.2008.00991.x","article-title":"Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome.","volume":"34","author":"Zhu","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"bcr2015212742","DOI":"10.1136\/bcr-2015-212742","article-title":"Dapsone hypersensitivity syndrome not related to G6PD deficiency.","volume":"2015","author":"Schulkes","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R18-20250707","doi-asserted-by":"crossref","first-page":"833","DOI":"10.47102\/annals-acadmedsg.V35N11p833","article-title":"Presumed dapsone-induced drughypersensitivity syndrome causing reversible hypersensitivity myocarditis and thyrotoxicosis.","volume":"35","author":"Teo","year":"2006","journal-title":"Ann Acad Med Singap"},{"key":"R19-20250707","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0022-3565(25)22309-6","article-title":"Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells.","volume":"245","author":"Uetrecht","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-20250707","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1385\/CRIAI:24:3:229","article-title":"Reactive metabolites and adverse drug reactions: clinical considerations.","volume":"24","author":"Knowles","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"R21-20250707","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the dapsone hypersensitivity syndrome.","volume":"369","author":"Zhang","year":"2013","journal-title":"N Engl J Med"},{"key":"R22-20250707","doi-asserted-by":"crossref","first-page":"658593","DOI":"10.3389\/fimmu.2021.658593","article-title":"Characterization of T-cell responses to SMX and SMX-NO in Co-trimoxazole hypersensitivity patients expressing HLA-B*13:01.","volume":"12","author":"Pratoomwun","year":"2021","journal-title":"Front Immunol"},{"key":"R23-20250707","doi-asserted-by":"crossref","first-page":"989837","DOI":"10.1155\/2013\/989837","article-title":"Role of HLA, KIR, MICA, and cytokines genes in leprosy.","volume":"2013","author":"Jarduli","year":"2013","journal-title":"Biomed Res Int"},{"key":"R24-20250707","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations.","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"R25-20250707","doi-asserted-by":"crossref","first-page":"709.e1","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: part II. Management and therapeutics.","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R26-20250707","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/cts.13201","article-title":"Efficacy of add-on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome.","volume":"15","author":"Sim","year":"2022","journal-title":"Clin Transl Sci"},{"key":"R27-20250707","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of cyclosporine for the treatment of DRESS syndrome.","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R28-20250707","doi-asserted-by":"crossref","first-page":"375","DOI":"10.47102\/annals-acadmedsg.V33N3p375","article-title":"Dapsone hypersensitivity syndrome masquerading as a viral exanthem: three cases and a mini-review.","volume":"33","author":"Tee","year":"2004","journal-title":"Ann Acad Med Singap"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:30:48Z","timestamp":1786041048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":28,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043073","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}